PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
03-Jun-2020 New First-in-Class Phase 3 TREMFYA®▼ (guselkumab) Data Demonstrate Improvement in Psoriatic Arthritis Joint and Skin Symptoms at Week 52 Janssen
03-Jun-2020 Envisagenics presents latest case study at Oligonucleotide Therapeutics and Delivery 2020 SMi Group Ltd
01-Jun-2020 Daiichi Sankyo and Syneos Health® Form Strategic Coalition for Development of Daiichi Sankyo’s ADC Oncology Pipeline Daiichi Sankyo, Inc.
01-Jun-2020 Sanofi announces closing of Regeneron stock sale Sanofi
01-Jun-2020 Sanifit Enhances Leadership Team with New Executive Appointments Sanifit
01-Jun-2020 Acacia Pharma Announces Debt for Equity Swap with Cosmo Pharmaceuticals Acacia Pharma Group plc
01-Jun-2020 ERYTECH Announces Poster Presentations at ASCO 2020 Annual Meeting ERYTECH Pharma
01-Jun-2020 MATINS Update - Safety and efficacy results from Part I of MATINS study presented in poster at ASCO20 Virtual - Patient recruitment for Part II in multiple cohorts progressing well Faron Pharmaceuticals Ltd
01-Jun-2020 MATINS Update - Safety and efficacy results from Part I of MATINS study presented in poster at ASCO20 Virtual - Patient recruitment for Part II in multiple cohorts progressing well Faron Pharmaceuticals Ltd
01-Jun-2020 MATINS Update - Safety and efficacy results from Part I of MATINS study presented in poster at ASCO20 Virtual - Patient recruitment for Part II in multiple cohorts progressing well Faron Pharmaceuticals Ltd
01-Jun-2020 Chi-Med Plans to Submit NDA for Surufatinib Following Pre-NDA Meeting with the U.S. FDA Chi-Med
01-Jun-2020 Lynparza recommended for approval in EU by CHMP for BRCA-mutated metastatic pancreatic cancer AstraZeneca PLC
01-Jun-2020 Immutep announces improving data from the phase II TACTI-002 study Immutep
01-Jun-2020 Immutep reports first results from INSIGHT-004 study Immutep Limited
01-Jun-2020 Calliditas Therapeutics launches US IPO roadshow and targets a capital raise of MUSD 75 Calliditas Therapeutics
01-Jun-2020 Almac Clinical Technologies Introduces SimplifyTM, an Advanced IRT Solution Enabling Faster Clinical Trials Start-up Almac Group
01-Jun-2020 Orgenesis to collaborate with The Edith Wolfson Medical Center to conduct clinical study using Orgenesis’ proprietary POCare technologies for the generation and expansion of Tumor Infiltrating Lymphocytes Orgenesis Inc
29-May-2020 Chi-Med Announces NDA Acceptance in China for Savolitinib in the Treatment of Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutations Chi-Med
29-May-2020 New number of shares and votes in Moberg Pharma AB (publ) Moberg Pharma
29-May-2020 Santhera Provides Update on the Ongoing Regulatory Review of Puldysa® (Idebenone) by the CHMP in Duchenne Muscular Dystrophy (DMD) Santhera Pharmaceuticals